MarginsXMarginsX
Home › Markets › Health Care › DRTS

Alpha Tau Medical Ltd. (DRTS)

DRTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$11.97
-10.54% on the day
Market cap
$1.1B
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDRTS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001871321
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inIsrael

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
5.5 months
$12.2M cash at December 31, 2025
Share count, 1 year
+25.0%
2024-12-31 to 2025-12-31 · +27.4% over 3 years
Going-concern doubt
No
20-F filed March 9, 2026
Insider net buying, 12 months
-$1.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-09
Cash and burn$12.2M cash; operating cash flow -$6.7M a quarter.Report 2025-12-31
Shares outstanding88,009,737 (2025-12-31); 70,380,570 a year earlier; 69,105,000 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-04-28
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKost Forer Gabbay & Kasierer, Tel Aviv, IsraelPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $1.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-$42.6M-$26.7M$12.2MNo debt tagsNeeds four quarters20-F 2026-03-09
FY 2024
2024-12-31
Not filed-$31.8M-$19.8M$13.7MNo debt tagsNeeds four quarters20-F 2026-03-09
FY 2023
2023-12-31
Not filed-$29.2M-$18.0M$12.7MNo debt tagsNeeds four quarters20-F 2026-03-09
FY 2022
2022-12-31
Not filed-$33.8M-$23.9M$5.8MNo debt tagsNeeds four quarters20-F 2025-03-12
FY 2021
2021-12-31
Not filed-$27.3M-$11.8M$23.2MNo debt tagsNeeds four quarters20-F 2024-03-07
FY 2020
2020-12-31
Not filed-$8.9M-$7.3M$15.6MNo debt tagsNeeds four quarters20-F 2023-03-09
FY 2019
2019-12-31
Not filed-$8.4M-$6.9M$1.8MNo debt tagsNeeds four quarters20-F 2022-03-28

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-04-28
Latest annual report
ANNUAL REPORT
20-F2026-03-09
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-16

Source: SEC EDGAR submissions feed, 242 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.5%
1 month-2.6%
3 months-7.7%
Year to date+170.3%
1 year+246.1%
From 52-week high-13.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
DRTSWAlpha Tau Medical Ltd. Warrant$2.02

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
NVCRNovoCure Limited$11.30-4.48%$1.3B
PRCTPROCEPT BioRobotics Corporation$23.54-1.09%$1.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier